Teva Pharmaceutical Industries Ltd (TEVA)
18.64
+0.19
(+1.03%)
USD |
NYSE |
Nov 04, 16:00
18.79
+0.15
(+0.80%)
After-Hours: 20:00
Teva Pharmaceutical Industries Total Assets (Quarterly): 41.34B for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 41.34B |
| March 31, 2024 | 42.77B |
| December 31, 2023 | 43.48B |
| September 30, 2023 | 42.09B |
| June 30, 2023 | 43.10B |
| March 31, 2023 | 43.46B |
| December 31, 2022 | 44.01B |
| September 30, 2022 | 44.25B |
| June 30, 2022 | 45.93B |
| March 31, 2022 | 47.06B |
| December 31, 2021 | 47.67B |
| September 30, 2021 | 47.85B |
| June 30, 2021 | 49.20B |
| March 31, 2021 | 49.00B |
| December 31, 2020 | 50.64B |
| September 30, 2020 | 49.74B |
| June 30, 2020 | 54.99B |
| March 31, 2020 | 55.33B |
| December 31, 2019 | 57.47B |
| September 30, 2019 | 57.25B |
| June 30, 2019 | 59.42B |
| March 31, 2019 | 59.85B |
| December 31, 2018 | 60.68B |
| September 30, 2018 | 65.06B |
| June 30, 2018 | 67.03B |
| Date | Value |
|---|---|
| March 31, 2018 | 69.18B |
| December 31, 2017 | 70.62B |
| September 30, 2017 | 86.08B |
| June 30, 2017 | 86.36B |
| March 31, 2017 | 91.28B |
| December 31, 2016 | 93.06B |
| September 30, 2016 | 98.75B |
| June 30, 2016 | 57.92B |
| March 31, 2016 | 55.13B |
| December 31, 2015 | 54.23B |
| September 30, 2015 | 48.62B |
| June 30, 2015 | 50.37B |
| March 31, 2015 | 46.95B |
| December 31, 2014 | 46.42B |
| September 30, 2014 | 46.61B |
| June 30, 2014 | 46.73B |
| March 31, 2014 | 46.89B |
| December 31, 2013 | 47.51B |
| September 30, 2013 | 47.85B |
| June 30, 2013 | 47.50B |
| March 31, 2013 | 48.07B |
| December 31, 2012 | 50.61B |
| September 30, 2012 | 49.58B |
| June 30, 2012 | 48.88B |
| March 31, 2012 | 50.47B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
41.34B
Minimum
Jun 2024
57.47B
Maximum
Dec 2019
47.34B
Average
47.06B
Median
Mar 2022
Total Assets (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 749.48M |
| Compugen Ltd | 110.17M |
| Pluri Inc | 39.53M |
| Can Fite Biofarma Ltd | 9.989M |
| BiomX Inc | 68.62M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 34.78B |
| Shareholders Equity (Quarterly) | 6.359B |
| Debt to Equity Ratio | 2.931 |
| Current Ratio | 0.8922 |
| Net Debt Paydown Yield | 2.23% |